
Storax 1000mg Tablet SR
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Citicoline (1000mg)
Overview Storax 1000mg Tablet SR
CerebralGuard 1000mg Extended-Release tablets aid in managing stroke, traumatic brain injury, Alzheimer's disease, and memory impairment associated with Parkinson's disease. This medication safeguards brain neurons from harm and facilitates their repair. CerebralGuard 1000mg ER tablets can be administered with or without food; however, consistent daily timing is recommended for optimal therapeutic levels. Dosage is individualized based on age and specific condition. Strictly adhere to your physician's prescribed dosage and duration; abrupt cessation may exacerbate symptoms. Potential side effects, including hypotension, gastrointestinal distress, arrhythmia, skin rash, sleep disturbances, and altered paresthesia, are typically transient. Consult your doctor if side effects persist or are bothersome. Prior to initiating treatment, disclose any history of renal impairment or seizures (epilepsy). Always inform your doctor of all current medications. If pregnant, planning pregnancy, or breastfeeding, discuss the use of this medication with your doctor beforehand.
Uses of Storax 1000mg Tablet SR
Management of cerebrovascular accidents | Management of traumatic brain injuries | Alzheimer's disease management | Dementia associated with Parkinson's disease management
Major Benefits of Storax 1000mg Tablet SR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. The tablet should be swallowed whole; avoid crushing, chewing, or breaking it. Storax 1000mg Sustained-Release Tablets can be ingested with or without food, though consistent timing is recommended.
Common Side effects of Storax 1000mg Tablet SR:
- Decreased blood pressure
- Arrhythmia (irregular heartbeats)
- Stomach pain
- Diarrhea
- Insomnia (difficulty in sleeping)
- Rash
- Peripheral neuropathy (tingling and numbness of feet and hand)
How to use Storax 1000mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 1000mg Storax SR tablet can be consumed with or without food, although consistent timing is recommended.
How Storax 1000mg Tablet SR works:
Storax 1000mg Sustained-Release tablets offer neuroprotective benefits. This medication promotes nerve cell health, shielding them from injury and enhancing their viability through the synthesis of key neurochemicals such as phosphatidylcholine and acetylcholine. Additionally, it mitigates the accumulation of free fatty acids at nerve injury sites.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of Storax 1000mg Tablet SR with alcohol is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on Storax 1000mg sustained-release tablets and pregnancy are lacking. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Storax 1000mg extended-release tablets and breastfeeding are currently unavailable. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Storax 1000mg Tablet SR on driving ability is undetermined. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Storax 1000mg sustained-release tablets. Dosage modification of Storax 1000mg sustained-release tablets may be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data on Storax 1000mg sustained-release tablets in patients with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Storax 1000mg Tablet SR :
Should you forget a Storax 1000mg Tablet SR dose, administer it immediately if feasible. Otherwise, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Storax 1000mg Tablet SR
| Label | Value |
|---|---|
| Chemical Type | Pyrimidine nucleotide diphosphate |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Action Category | Cognitive enhancer |
